These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
629 related articles for article (PubMed ID: 33130800)
1. Does HAS-BLED risk score underestimate the risk of bleeding in patients with triple antithrombotic therapy? Stojanovic M; Deljanin-Ilic M; Ilic S; Ilic B; Petrovic D Pol Merkur Lekarski; 2020 Oct; 48(287):361-364. PubMed ID: 33130800 [TBL] [Abstract][Full Text] [Related]
2. Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials? Duerschmied D; Brachmann J; Darius H; Frey N; Katus HA; Rottbauer W; Schäfer A; Thiele H; Bode C; Zeymer U Clin Res Cardiol; 2018 Jul; 107(7):533-538. PubMed ID: 29679144 [TBL] [Abstract][Full Text] [Related]
3. The role of triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention. Fanaroff AC; Lopes RD Prog Cardiovasc Dis; 2021; 69():11-17. PubMed ID: 34883097 [TBL] [Abstract][Full Text] [Related]
4. Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention. Saito Y; Kobayashi Y J Cardiol; 2019 Jan; 73(1):1-6. PubMed ID: 30293674 [TBL] [Abstract][Full Text] [Related]
5. Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents. Choi HI; Ahn JM; Kang SH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ JACC Cardiovasc Interv; 2017 Jun; 10(11):1075-1085. PubMed ID: 28527773 [TBL] [Abstract][Full Text] [Related]
6. Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation: The RE-DUAL PCI Trial Subanalysis. Ten Berg JM; de Veer A; Oldgren J; Steg PG; Zateyshchikov DA; Jansky P; Seung KB; Hohnloser SH; Lip GYH; Nordaby M; Kleine E; Bhatt DL; Cannon CP; JACC Cardiovasc Interv; 2019 Dec; 12(23):2331-2341. PubMed ID: 31806214 [TBL] [Abstract][Full Text] [Related]
7. Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysis. Haller PM; Sulzgruber P; Kaufmann C; Geelhoed B; Tamargo J; Wassmann S; Schnabel RB; Westermann D; Huber K; Niessner A; Gremmel T Eur Heart J Cardiovasc Pharmacother; 2019 Oct; 5(4):226-236. PubMed ID: 31198930 [TBL] [Abstract][Full Text] [Related]
8. The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE-DUAL PCI subgroup analysis and comparison to other dual antithrombotic therapy trials). Eccleston DS; Kim JM; Ten Berg JM; Steg PG; Bhatt DL; Hohnloser SH; de Veer A; Nordaby M; Miede C; Kimura T; Lip GYH; Oldgren J; Cannon CP Clin Cardiol; 2021 Jul; 44(7):1002-1010. PubMed ID: 34042199 [TBL] [Abstract][Full Text] [Related]
9. Antithrombotic therapy according to baseline bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: applying the PRECISE-DAPT score in RE-DUAL PCI. Costa F; Valgimigli M; Steg PG; Bhatt DL; Hohnloser SH; Ten Berg JM; Miede C; Nordaby M; Lip GYH; Oldgren J; Cannon CP Eur Heart J Cardiovasc Pharmacother; 2022 May; 8(3):216-226. PubMed ID: 33258897 [TBL] [Abstract][Full Text] [Related]
10. Antithrombotic Treatment after Carotid Stenting in Patients with Concomitant Atrial Fibrillation. Pardo-Galiana B; Medina-Rodriguez M; Millan-Vazquez M; Cabezas-Rodriguez JA; Lebrato-Hernandez L; Ainz-Gomez L; Zapata-Arriaza E; Ortega J; de Albóniga-Chindurza A; Montaner J; Gonzalez A; Moniche F AJNR Am J Neuroradiol; 2022 May; 43(5):727-730. PubMed ID: 35393364 [TBL] [Abstract][Full Text] [Related]
11. Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial. Windecker S; Lopes RD; Massaro T; Jones-Burton C; Granger CB; Aronson R; Heizer G; Goodman SG; Darius H; Jones WS; Aschermann M; Brieger D; Cura F; Engstrøm T; Fridrich V; Halvorsen S; Huber K; Kang HJ; Leiva-Pons JL; Lewis BS; Malaga G; Meneveau N; Merkely B; Milicic D; Morais J; Potpara TS; Raev D; Sabaté M; de Waha-Thiele S; Welsh RC; Xavier D; Mehran R; Alexander JH; Circulation; 2019 Dec; 140(23):1921-1932. PubMed ID: 31557056 [TBL] [Abstract][Full Text] [Related]
12. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease. Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080 [TBL] [Abstract][Full Text] [Related]
13. Contemporary Antithrombotic Treatment in Patients with Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Rationale and Design of the Greek AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry. Xanthopoulou I; Dragona VM; Davlouros P; Tsioufis C; Iliodromitis E; Alexopoulos D; Cardiovasc Drugs Ther; 2018 Apr; 32(2):191-196. PubMed ID: 29679301 [TBL] [Abstract][Full Text] [Related]
14. Triple antithrombotic therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation. Kang DO; Yu CW; Kim HD; Cho JY; Joo HJ; Choi RK; Park JS; Lee HJ; Kim JS; Park JH; Hong SJ; Lim DS Coron Artery Dis; 2015 Aug; 26(5):372-80. PubMed ID: 25768244 [TBL] [Abstract][Full Text] [Related]
15. Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation. Cannon CP; Bhatt DL; Oldgren J; Lip GYH; Ellis SG; Kimura T; Maeng M; Merkely B; Zeymer U; Gropper S; Nordaby M; Kleine E; Harper R; Manassie J; Januzzi JL; Ten Berg JM; Steg PG; Hohnloser SH; N Engl J Med; 2017 Oct; 377(16):1513-1524. PubMed ID: 28844193 [TBL] [Abstract][Full Text] [Related]
16. Intracranial haemorrhages vs. stent thromboses with direct oral anticoagulant plus single antiplatelet agent or triple antithrombotic therapy: a meta-analysis of randomized trials in atrial fibrillation and percutaneous coronary intervention/acute coronary syndrome patients. Galli M; Andreotti F; Porto I; Crea F Europace; 2020 Apr; 22(4):538-546. PubMed ID: 31942971 [TBL] [Abstract][Full Text] [Related]
17. Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. Camaj A; Miller MS; Halperin JL; Giustino G Cardiol Clin; 2020 Nov; 38(4):551-561. PubMed ID: 33036717 [TBL] [Abstract][Full Text] [Related]
18. Antithrombotic therapy in atrial fibrillation patients with coronary artery disease: shifting paradigm to a "less is more" concept regimen. Kawakami S; Yasuda S; Ogawa H J Cardiol; 2020 Jul; 76(1):35-43. PubMed ID: 32389534 [TBL] [Abstract][Full Text] [Related]
19. Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease. Thompson PL; Verheugt FW Clin Ther; 2014 Sep; 36(9):1176-81. PubMed ID: 25234549 [TBL] [Abstract][Full Text] [Related]
20. Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update. Angiolillo DJ; Goodman SG; Bhatt DL; Eikelboom JW; Price MJ; Moliterno DJ; Cannon CP; Tanguay JF; Granger CB; Mauri L; Holmes DR; Gibson CM; Faxon DP Circulation; 2018 Jul; 138(5):527-536. PubMed ID: 30571525 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]